General Information of This Drug (ID: DMP7X6Q)

Drug Name
Rotigotine   DMP7X6Q
Synonyms
Rotigotine; Rotigotine CDS; Rotigotine CDS Patch; SPM 962; SPM-962; (-)-(S)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol; Leganto; N 0923; Neupro; (6S)-6-(Propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol; (6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol; (S)-6-(propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol; 87T4T8BO2E; 99755-59-6; C19H25NOS; CHEMBL1303; DSSTox_CID_26772; DSSTox_RID_81893; NCGC00168748-01; UNII-87T4T8BO2E
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Levodopa + Rotigotine DC1M73G Levodopa Idiopathic Parkinson's Disease [1]
Rotigotine + Rotigotine DCI49DI Rotigotine Restless Legs Syndrome [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01646255) Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients
2 ClinicalTrials.gov (NCT03992196) A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome